Karyopharm Drops 40% After FDA Posts Selinexor Meeting Briefing Docs
February 22, 2019 at 14:49 PM EST
Shares of Karyopharm are moving sharply lower after the FDA posted briefing documents for the Oncologic Drugs Advisory Committee Meeting planned for February 26 to review the New Drug Application for Selinexor.
